Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2007; 13(21): 2945-2951
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2945
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2945
Figure 1 A: Survival rates of all pancreatic cancers; B: Survival rates of ductal adenocarcinomas.
CRR: chemoradiation and resection; RO: resection only.
Figure 2 Survival rates of pancreatic cancers.
A: with nodal involvement; B: without nodal involvement. CRR: chemoradiation and resection; RO: resection only; LN: lymph node.
Figure 3 Survival rates of ductal adenocarcinomas.
A: with nodal involvement; B: without nodal involvement. CRR: chemoradiation and resection; RO: resection only; LN: lymph node.
- Citation: Vento P, Mustonen H, Joensuu T, Kärkkäinen P, Kivilaakso E, Kiviluoto T. Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer. World J Gastroenterol 2007; 13(21): 2945-2951
- URL: https://www.wjgnet.com/1007-9327/full/v13/i21/2945.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i21.2945